AU2009285530A1 - High-throughput and non-invasive method to vitrify porcine embryos - Google Patents
High-throughput and non-invasive method to vitrify porcine embryos Download PDFInfo
- Publication number
- AU2009285530A1 AU2009285530A1 AU2009285530A AU2009285530A AU2009285530A1 AU 2009285530 A1 AU2009285530 A1 AU 2009285530A1 AU 2009285530 A AU2009285530 A AU 2009285530A AU 2009285530 A AU2009285530 A AU 2009285530A AU 2009285530 A1 AU2009285530 A1 AU 2009285530A1
- Authority
- AU
- Australia
- Prior art keywords
- embryos
- embryo
- lipid
- porcine
- vitro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 210000002257 embryonic structure Anatomy 0.000 title claims description 100
- 238000000034 method Methods 0.000 title claims description 30
- 150000002632 lipids Chemical class 0.000 claims description 33
- 210000001161 mammalian embryo Anatomy 0.000 claims description 32
- 238000005119 centrifugation Methods 0.000 claims description 30
- 238000000926 separation method Methods 0.000 claims description 20
- 238000005138 cryopreservation Methods 0.000 claims description 16
- 210000002459 blastocyst Anatomy 0.000 claims description 12
- 238000004017 vitrification Methods 0.000 claims description 11
- 238000000338 in vitro Methods 0.000 claims description 10
- 238000012546 transfer Methods 0.000 claims description 10
- 210000004340 zona pellucida Anatomy 0.000 claims description 9
- 101100024019 Mus musculus Mosmo gene Proteins 0.000 claims description 8
- 238000003776 cleavage reaction Methods 0.000 claims description 8
- 238000005056 compaction Methods 0.000 claims description 8
- 230000007017 scission Effects 0.000 claims description 8
- 238000011084 recovery Methods 0.000 claims description 3
- 238000012258 culturing Methods 0.000 claims description 2
- 230000004720 fertilization Effects 0.000 claims description 2
- 238000010792 warming Methods 0.000 claims description 2
- 238000007710 freezing Methods 0.000 claims 1
- 230000008014 freezing Effects 0.000 claims 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 26
- 239000002609 medium Substances 0.000 description 19
- 210000000287 oocyte Anatomy 0.000 description 19
- 238000011282 treatment Methods 0.000 description 19
- 239000011780 sodium chloride Substances 0.000 description 13
- 229930006000 Sucrose Natural products 0.000 description 12
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 12
- 239000005720 sucrose Substances 0.000 description 12
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 11
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 9
- 241000282898 Sus scrofa Species 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 210000000805 cytoplasm Anatomy 0.000 description 5
- 238000011161 development Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- 230000006862 enzymatic digestion Effects 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 239000007995 HEPES buffer Substances 0.000 description 4
- 108010059712 Pronase Proteins 0.000 description 4
- 230000004913 activation Effects 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 230000004927 fusion Effects 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 230000035800 maturation Effects 0.000 description 4
- 230000035935 pregnancy Effects 0.000 description 4
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 3
- 229930195725 Mannitol Natural products 0.000 description 3
- -1 NaCl Chemical class 0.000 description 3
- 210000001109 blastomere Anatomy 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 230000009027 insemination Effects 0.000 description 3
- 239000000594 mannitol Substances 0.000 description 3
- 235000010355 mannitol Nutrition 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 238000010561 standard procedure Methods 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 108010003272 Hyaluronate lyase Proteins 0.000 description 2
- 102000001974 Hyaluronidases Human genes 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 108090000631 Trypsin Proteins 0.000 description 2
- 102000004142 Trypsin Human genes 0.000 description 2
- GBOGMAARMMDZGR-UHFFFAOYSA-N UNPD149280 Natural products N1C(=O)C23OC(=O)C=CC(O)CCCC(C)CC=CC3C(O)C(=C)C(C)C2C1CC1=CC=CC=C1 GBOGMAARMMDZGR-UHFFFAOYSA-N 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 210000001771 cumulus cell Anatomy 0.000 description 2
- GBOGMAARMMDZGR-JREHFAHYSA-N cytochalasin B Natural products C[C@H]1CCC[C@@H](O)C=CC(=O)O[C@@]23[C@H](C=CC1)[C@H](O)C(=C)[C@@H](C)[C@@H]2[C@H](Cc4ccccc4)NC3=O GBOGMAARMMDZGR-JREHFAHYSA-N 0.000 description 2
- GBOGMAARMMDZGR-TYHYBEHESA-N cytochalasin B Chemical compound C([C@H]1[C@@H]2[C@@H](C([C@@H](O)[C@@H]3/C=C/C[C@H](C)CCC[C@@H](O)/C=C/C(=O)O[C@@]23C(=O)N1)=C)C)C1=CC=CC=C1 GBOGMAARMMDZGR-TYHYBEHESA-N 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000011067 equilibration Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229960002773 hyaluronidase Drugs 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000001776 parthenogenetic effect Effects 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 210000004508 polar body Anatomy 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 229940054269 sodium pyruvate Drugs 0.000 description 2
- 239000010902 straw Substances 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 230000009261 transgenic effect Effects 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical class OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 238000003260 vortexing Methods 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102000009024 Epidermal Growth Factor Human genes 0.000 description 1
- 101800003838 Epidermal growth factor Proteins 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 229930182566 Gentamicin Natural products 0.000 description 1
- CEAZRRDELHUEMR-URQXQFDESA-N Gentamicin Chemical compound O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N CEAZRRDELHUEMR-URQXQFDESA-N 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000003636 conditioned culture medium Substances 0.000 description 1
- 210000004292 cytoskeleton Anatomy 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000000368 destabilizing effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000013020 embryo development Effects 0.000 description 1
- 238000003890 embryo preservation Methods 0.000 description 1
- 229940116977 epidermal growth factor Drugs 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 238000012239 gene modification Methods 0.000 description 1
- 230000005017 genetic modification Effects 0.000 description 1
- 235000013617 genetically modified food Nutrition 0.000 description 1
- 229960002518 gentamicin Drugs 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- VVIUBCNYACGLLV-UHFFFAOYSA-N hypotaurine Chemical compound [NH3+]CCS([O-])=O VVIUBCNYACGLLV-UHFFFAOYSA-N 0.000 description 1
- 230000002631 hypothermal effect Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 210000003101 oviduct Anatomy 0.000 description 1
- 230000009340 pathogen transmission Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 229940076788 pyruvate Drugs 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
- 229940033663 thimerosal Drugs 0.000 description 1
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 238000002689 xenotransplantation Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/122—Preservation or perfusion media
- A01N1/125—Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19051508P | 2008-08-29 | 2008-08-29 | |
| US61/190,515 | 2008-08-29 | ||
| PCT/US2009/055424 WO2010025404A1 (en) | 2008-08-29 | 2009-08-28 | High-throughput and non-invasive method to vitrify porcine embryos |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2009285530A1 true AU2009285530A1 (en) | 2010-03-04 |
Family
ID=41721960
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2009285530A Abandoned AU2009285530A1 (en) | 2008-08-29 | 2009-08-28 | High-throughput and non-invasive method to vitrify porcine embryos |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US8852078B2 (enExample) |
| EP (1) | EP2331677A4 (enExample) |
| JP (1) | JP2012501187A (enExample) |
| CN (1) | CN102197130A (enExample) |
| AU (1) | AU2009285530A1 (enExample) |
| BR (1) | BRPI0918262A2 (enExample) |
| CA (1) | CA2741754A1 (enExample) |
| CL (1) | CL2011000438A1 (enExample) |
| WO (1) | WO2010025404A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9433195B2 (en) | 2012-06-06 | 2016-09-06 | Inguran, Llc | Methods for increasing genetic progress in a line or breed of swine using sex-selected sperm cells |
| US9888990B2 (en) | 2012-06-06 | 2018-02-13 | Inguran, Llc | Methods for use of sex sorted semen to improve genetic management in swine |
| WO2017099865A1 (en) | 2015-12-07 | 2017-06-15 | Coopersurgical, Inc. | Low temperature specimen carriers and related methods |
| US11856947B2 (en) | 2020-02-17 | 2024-01-02 | Cook Medical Technologies Llc | System for automated permeation of a biological material and method of using same |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995005075A1 (en) * | 1993-08-13 | 1995-02-23 | Bresatec Limited | Cryopreservation of porcine embryos |
| US6485959B1 (en) * | 1998-10-07 | 2002-11-26 | Cedars Sinai Medical Center | Cell preconditioning and cryopresevation medium |
| US20040161735A1 (en) * | 1998-11-24 | 2004-08-19 | The University Of Queensland | Cryopreservation of oocytes and embryos and methods for producing animals involving the same |
| US20020045156A1 (en) * | 2000-05-16 | 2002-04-18 | Mehmet Toner | Microinjection of cryoprotectants for preservation of cells |
| US6503698B1 (en) * | 2000-06-16 | 2003-01-07 | The United States Of America As Represented By The Secretary Of Agriculture | Cryopreservation of swine embryos |
| CN1199688C (zh) * | 2003-06-05 | 2005-05-04 | 于靖波 | 促卵巢功能细胞生长素及其制备方法 |
-
2009
- 2009-08-28 BR BRPI0918262A patent/BRPI0918262A2/pt not_active IP Right Cessation
- 2009-08-28 WO PCT/US2009/055424 patent/WO2010025404A1/en not_active Ceased
- 2009-08-28 US US13/061,222 patent/US8852078B2/en not_active Expired - Fee Related
- 2009-08-28 JP JP2011525249A patent/JP2012501187A/ja active Pending
- 2009-08-28 CN CN2009801428076A patent/CN102197130A/zh active Pending
- 2009-08-28 AU AU2009285530A patent/AU2009285530A1/en not_active Abandoned
- 2009-08-28 CA CA2741754A patent/CA2741754A1/en not_active Abandoned
- 2009-08-28 EP EP09810683.4A patent/EP2331677A4/en not_active Withdrawn
-
2011
- 2011-02-28 CL CL2011000438A patent/CL2011000438A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2741754A1 (en) | 2010-03-04 |
| WO2010025404A1 (en) | 2010-03-04 |
| EP2331677A4 (en) | 2013-07-24 |
| US8852078B2 (en) | 2014-10-07 |
| BRPI0918262A2 (pt) | 2016-07-26 |
| EP2331677A1 (en) | 2011-06-15 |
| CN102197130A (zh) | 2011-09-21 |
| JP2012501187A (ja) | 2012-01-19 |
| US20110213198A1 (en) | 2011-09-01 |
| CL2011000438A1 (es) | 2011-07-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Rayos et al. | Quick freezing of unfertilized mouse oocytes using ethylene glycol with sucrose or trehalose | |
| Michelmann et al. | Cryopreservation of human embryos | |
| Orief et al. | Vitrification: will it replace the conventional gamete cryopreservation techniques? | |
| Li et al. | Production of piglets after cryopreservation of embryos using a centrifugation-based method for delipation without micromanipulation | |
| Aljaser | Cryopreservation Methods and Frontiers in the Art of Freezing | |
| US8852078B2 (en) | High-throughput and non-invasive method to vitrify porcine embryos | |
| Steel et al. | 120 Pregnancy rates resulting from transfer of fresh and frozen Holstein and Jersey embryos | |
| JP2012501187A5 (enExample) | ||
| Moulavi et al. | Survival, re-expansion, and pregnancy outcome following vitrification of dromedary camel cloned blastocysts: a possible role of vitrification in improving clone pregnancy rate by weeding out poor competent embryos | |
| Endoh et al. | The developmental ability of vitrified oocytes from different mouse strains assessed by parthenogenetic activation and intracytoplasmic sperm injection | |
| McCue et al. | 109 Refreezing stallion spermatozoa for assisted reproduction | |
| Baranyai et al. | Vitrification of biopsied mouse embryos | |
| Songsasen et al. | -A Historical Overview of Embryo and Oocyte Preservation in the World of Mammalian In Vitro Fertilization and Biotechnology | |
| Kelly et al. | 102 vitrification of in vitro-produced bovine and ovine embryos using the minimum volume cooling Cryotop method | |
| HK1160885A (en) | High-throughput and non-invasive method to vitrify porcine embryos | |
| Cremades et al. | 92 The addition of seminal plasma from individual boars to freezing extender can improve the post-thaw sperm survival | |
| Williams et al. | 124 Cryopreservation of white-tailed deer (Odocoileus virginianus) semen | |
| Gajda et al. | Current and potential use of cryopreservation of farm animal embryos and oocytes | |
| Dinnyes et al. | 95 First report on cleavage development following cryopreservation of adult and prepubertal rhesus monkey (Macaca Mulatta) oocytes | |
| Sagirkaya et al. | 118 Vitrification of pronuclear-stage mouse embryos on aluminum foil floating on liquid nitrogen | |
| Collins | 90 Effective viability threshold for preserved honey bee semen | |
| Matsas et al. | 108 Cryopreservation of germplasm from heritage breeds of domestic livestock: seasonal effects On superovulation response and embryo production | |
| Matoba et al. | 107 Toxicity of ethylene glycol on frozen and thawed IVP embryos in direct transfer method | |
| Goda et al. | 97 Effect of rapid temperature change on viability of frozen-thawed IVM/IVF bovine embryos | |
| Camargo et al. | 86 COMPARISON OF TWO VITRIFICATION PROTOCOLS FOR CROSSBREDBOS INDICUS× BOS TAURUS IN VITRO-PRODUCED EMBRYOS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK4 | Application lapsed section 142(2)(d) - no continuation fee paid for the application |